Table 1.

Detailed description of 10 studies.

References	ALL_n	Age, years, mean (SD)(E/C)	Paretic side (n: right/left)(E/C)	Time since stroke onset, day, mean (SD)(E/C)	Clinical stage	Severity (Brunnstrom stages) (E/C)	Type	Interventions(E/C)
Wang and Chen (33)	60	47.02 ± 9.1/48.08 ± 10.2	11/19 10/20	119.26 ± 41.08/120.37 ± 39.4	Subcute	Unclear	EMGBF	EMGBF+MT+CT/EMGBT+CT
Xu (34)	40	62.40 ± 8.61/60.65 ± 8.80	13/7 12/8	17.61 ± 7.63/15.36 ± 8.19	Subcute	1.15 ± 0.37/1.20 ± 0.41	EMGBF	EMGBF+MT+CT/EMGBF+CT
Yao (21)	60	57.40 ± 7.323/57.07 ± 6.181	14/16 14/16	18.03 ± 5.654/21.23 ± 8.365	Subcute	2.93 ± 1.0065/2.67 ± 1.011	EMGBF	EMGBF+MT+CT/EMGBF+CT
Xie et al. (35)	90	56 ± 8/54 ± 6	27/18 21/24	40.73 ± 6.75/42.69 ± 7.42	Subcute	Unclear	AT	AT+MT+CT /MT+CT
Zhang et al. (36)	40	55.2 ± 10.9/54.9 ± 11.3	11/9 8/12	19.6 ± 20.3/30.8 ± 28.7	Subcute	2.15 ± 0.726/1.9 ± 0.70	AT	AT+MT+CT /MT+CT
Zhou and Ye (30)	40	57.22 ± 6.15/54.20 ± 5.03	unclear	<8 weeks	Subcute	Unclear	AT	AT+MT+CT /MT+CT
Lin et al. (37)	28	55.79 ± 14.59 /56.01+12.53	8/6 6/8	158.97 ± 95.34/129.5 ± 81.27	Chronic	4.25 ± 0.64 /4.25 ± 0.64	MG	MG+MT+CT/MT+CT
Lee et al. (10)	32	52.50+13.24 /56.64+9.43	7/8 7/10	660 ± 421.2 /531.3 ± 397.2	Chronic	Unclear	MG	MG+MT+CT /MT+CT
Kim et al. (31)	23	55.92 ± 11.75/55.64 ± 12.61	4/8 6/5	34.06 ± 1.65/35.00 ± 15.05	Subcute	3.5 ± 0.97/3.28 ± 1.051	ES	ES+MT +CT /ES+CT
Schick et al. (18)	32	62 ± 19.6 /63 ± 11.5	7/8 8/9	1–6 months	Subcute	Unclear	ES	ES+MT+CT/ES+CT